BLACK WEEKSInjektiopullot −15 % · kitit −10 % · muut −5 %koodillaIlmainen toimitus Saksaan alk. €200

Tämä sivu on käännetty automaattisesti, ja siinä voi olla virheitä. Onko suomi äidinkielesi? Otamme mielellämme vastaan palautetta ja korjauksia.Lähetä palautetta

The Peptide Desk The Peptide Desk

Nämä tiedot on tarkoitettu ainoastaan tutkimus- ja koulutustarkoituksiin. Ei lääketieteellisiä suosituksia. Tuotteita ei ole hyväksytty ihmiskäyttöön. Terveyteen liittyvissä kysymyksissä käänny lääkärin puoleen.

Tietopankki

DNP (2,4-dinitrophenol)

The historical mitochondrial uncoupler with the narrowest safety window in the whole range: documented deaths from overheating, no antidote and no dose that can be defended in humans.

8 min read 10 sources

White tablet bottle with a black TPD label for DNP on a white podium, next to it a large blue and white 3D model of the molecule with a six-membered ring in a bright lab
Banned for human use · not approved

Summary

At a glance

Sources checked on 26 Oct 2026

Documented in the medical literature
62 deaths

2011 review, typically overheating with racing heart and sweating1

Fatal outcome
11.9 %

456 cases at poisons centres in 38 countries, where the outcome was known3

Fever in poisonings
47 %

30 reported cases in the UK, racing heart 43%, sweating 37%4

Specific antidote
0 antidotes

Treatment only of the consequences, the uncoupling cannot be switched off2

Trials with free DNP in the registry
0 trials

only the precursor HU6 is being tested, as of 26 Oct 20269

  • DNP (2,4-dinitrophenol) is an industrial chemical and the oldest known mitochondrial uncoupler. Energy from fat and sugar is no longer stored as ATP but released as heat.510
  • Because of its toxicity DNP has been banned for human use in many countries since 1938. The medical literature records 62 deaths, typically from overheating with a racing heart and sweating.21
  • Of 456 cases reported to poisons centres in 38 countries, 11.9 percent were fatal where the outcome was known. There is no specific antidote.32
  • Today only the precursor HU6 is being tested, which the liver converts into DNP: in a phase 2a trial liver fat fell by up to 35.6 percent, on placebo it rose slightly.6
  • There is no registered trial and no approval for the free substance. Everything here is the state of research, not a recommendation.9
Profiili

Updated October 2026

Class
Mitochondrial uncoupler

protonophore, not a hormone, not a steroid

Form
Oral tablet
Half-life
Barely studied in humans

elimination over several days in poisoning cases

Dosing
No defensible human protocol

we give no dose

Status
Banned for human consumption in many countries since 1938, no known antidote
Risk
Highest tier in the range

documented deaths

Sizes
200 mg

2 sizes in the shop

Sisältö 13 sections
  1. Yhdellä silmäyksellä
  2. What is DNP?
  3. How it works
  4. Why the safety window is so narrow
  5. Use and dosing
  6. What the research shows
  7. Tutkimustilanne
  8. Side effects
  9. Storage
  10. Samankaltaiset yhdisteet
  11. UKK
  12. Sanasto
  13. Lähteet

What is DNP?

DNP stands for 2,4-dinitrophenol, a yellow industrial chemical that is also the historical prototype of the mitochondrial uncouplers. During the First World War it was handled in French munitions factories, where workers were poisoned and some died. In 1933 Maurice Tainter at Stanford University reported that taking it caused marked weight loss in humans. Soon afterwards DNP was sold over the counter as a slimming aid (Grundlingh, J Med Toxicol 2011).

The compound did not disappear because it failed to work. It disappeared because of deaths and rapidly developing cataracts. In 1938 the US classified DNP as extremely dangerous and not fit for human consumption. Many countries have banned it for human consumption since (Sousa, Arch Toxicol 2020). In research it remains a standard tool for studying oxidative phosphorylation. That is where it genuinely belongs.

This entry is therefore built differently from the others: it gives no dose. The toxicology literature does not support any range that can be defended in humans. We do not invent one. In the range DNP comes as a tablet containing 200 mg, 50 tablets per tin.

This information is for research and educational purposes only. No medical advice.

Comparison

Uncouplers compared

DNP, BAM15 and the combo with SLU-PP-332, as described in the TPD lexicon. Tap a card to open its entry.

Simplified: all three act on the mitochondria. In its first description BAM15 did not depolarise the outer cell membrane. There is no comparison in humans. 85

How it works

In cellular respiration, mitochondria pump protons out of the matrix and build a gradient across the inner membrane. When those protons flow back through ATP synthase, ATP is made, the energy currency of the cell. In the classic model DNP is a small, lipophilic molecule carrying a dissociable proton: it picks up a proton on the acidic outer side, crosses the membrane and releases it in the matrix.

That bypasses ATP synthase. The energy from oxidising fats and sugars is no longer packaged into ATP but released as heat. The cell registers the shortfall and raises turnover, burning more substrate for the same result. This uncoupling is a real and long established effect. It is why the substance looked so attractive historically.

The effect is neither organ specific nor adjustable. Every cell with mitochondria is affected. There is no receptor and no counterpart through which the body could push back. Recent work shows that transport proteins of the inner mitochondrial membrane, such as the ADP/ATP carrier and the uncoupling proteins, further amplify the protonophoric action. Exactly how uncoupling proceeds at the molecular level is still not fully resolved (Pohl and Jovanović, Eur Biophys J 2026).

Where it acts

What DNP does in the body

Tap a point or a card. Grey = observed in poisonings or trials. There is no receptor, every cell with mitochondria is affected.

  1. Heart

    Racing heart in 43% of reported poisonings4

    Observed in trials
  2. Skin

    Fever 47%, sweating 37%, discolouration or rash 23%4

    Observed in trials
  3. Lungs

    Rapid breathing, breathing difficulties in 23%4

    Observed in trials
  4. Kidney

    Acute kidney failure as part of the poisoning2

    Observed in trials
  5. Circulation

    Falling blood pressure in poisoning2

    Observed in trials
  6. Liver

    Converts the precursor HU6 into DNP, liver fat down to -35.6%6

    Observed in trials
Transparent glass model of a mitochondrion with a folded inner membrane, inside two blue molecules and a stream of golden light points leaving on the right as heat
Uncoupling: energy escapes as heat instead of ATP. Symbolic image.

Why the safety window is so narrow

With most substances there is a buffer between the amount that does something and the amount that does harm. With DNP that buffer was already described as small when doctors prescribed it in the 1930s. Its width cannot be predicted for an individual. Grundlingh and colleagues describe substantial variation in individual response: the same amount can act very differently in two people (J Med Toxicol 2011).

Poisoning runs through exactly the mechanism that produces the effect. When too much heat is released, body temperature rises faster than the body can shed it through sweating and breathing. Past a certain point the process reinforces itself, because metabolic rate climbs further with temperature. There is no way to switch the uncoupling off from outside. There is no specific antidote either (Sousa, Arch Toxicol 2020).

The second point is slow elimination. In case reports it stretched over several days, so repeated doses can add up: an amount that passes without consequence on one day can, together with what is left from previous days, reach the critical range. In the UK series 16 of 30 cases involved repeated intake over days to a few weeks and 12 a single overdose (Kamour, Emerg Med J 2014). Heat, physical exertion, warm surroundings and too little fluid additionally block the very routes by which the body sheds that heat.

Use and dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts
White tablet bottle with a black TPD label for DNP, a few round white tablets beside it on a bright lab bench
No dose given, see text. Symbolic image.

What the research shows

Grundlingh and colleagues (J Med Toxicol 2011) collected the published cases and counted 62 deaths documented in the medical literature. They describe a consistent picture of hyperthermia, tachycardia, heavy sweating and rapid breathing that can end in death. Even for the medical use of the 1930s, they note that the wanted and the toxic effects lie close together.

Gziut and Thomas (Clin Toxicol 2021) worked with the WHO to contact poisons centres worldwide and received data from 38 countries on 456 exposure cases between January 2010 and September 2020. Annual cases rose from 4 in 2010 to 71 in 2015 and still stood at 53 in 2019. Where the outcome was known, 11.9 percent of cases were fatal, with no significant difference between women and men. The authors describe fatal outcomes as common.

Kamour and colleagues (Emerg Med J 2014) analysed reports to the UK National Poisons Information Service from 2007 to 2013: 30 cases, 22 of them in 2013 alone, 27 of them men, median age 23.5 years. The most common features were fever in 47 percent, tachycardia in 43 percent and sweating in 37 percent, alongside nausea or vomiting, skin discolouration or rash, breathing difficulty and abdominal pain. Five of the 30 cases were fatal, four of them after an acute overdose.

Sousa and colleagues (Arch Toxicol 2020) summarise the current position: hyperthermia, tachycardia, falling blood pressure and acute renal failure as the core picture of poisoning, a 2015 warning from the Interpol anti-doping unit and no specific antidote or treatment available. Pohl and Jovanović (Eur Biophys J 2026) place the mechanism in context and name the open problem: until the molecular detail of uncoupling is properly understood, there is neither a mechanism based antidote nor a safer successor.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

Most common signs in DNP poisonings4

Share of 30 cases in percent, UK National Poisons Information Service 2007 to 2013

Fever4
Reported cases, UK 47%
Racing heart4
Reported cases, UK 43%
Sweating4
Reported cases, UK 37%
Nausea or vomiting4
Reported cases, UK 27%
Skin discolouration or rash4
Reported cases, UK 23%
Breathing difficulties4
Reported cases, UK 23%

Plus abdominal pain in 23 percent, agitation and headache in 13 percent each. 27 of the 30 people were men, median age 23.5 years. These signs are not a sign of effect but the picture of poisoning.

Share of fatal outcomes34

In percent of cases, two analyses of poisons centre data

38 countries, 2010 to 20203 456 cases, only where the outcome was known
Poisons centres, 38 countries 11.9%
UK, 2007 to 20134 5 of 30 cases
Reported cases, UK 17.0%

Internationally the number of cases rose from 4 in 2010 to 71 in 2015 and was still 53 in 2019. In the UK four of the five deaths followed an acute overdose.

Liver fat after 61 days with the precursor HU66

Relative change in percent, 80 adults with fatty liver and overweight, phase 2a

Liver fat (MRI)6
Placebo +5.4%
HU6, lowest level -26.8%
HU6, middle level -35.6%
HU6, highest level -33.0%

The trial tested HU6, not DNP: a precursor that the liver converts into DNP. No serious adverse events and no deaths occurred in this trial.

HU6 in heart failure with obesity7

Difference from placebo after 19 weeks in kg, 66 participants, phase 2a

Body weight7
Precursor HU6 -2.86 kg
Fat mass7
Precursor HU6 -2.96 kg

Without significant loss of muscle mass. Exercise capacity (oxygen uptake), walking distance and quality of life did not change significantly. Serious events in 4 people on HU6 and 1 on placebo, judged unrelated to treatment by the trial.

Yellowish fat tissue sample in a glass dish on a metal shelf in a lab cabinet, light steam above it, stacked petri dishes around it
Human data come almost only from poisoning cases. Symbolic image.

Research status

Where the research stands

The registry lists no trial with free DNP. Only the precursor HU6 (phase 1 and 2) is being tested, which the liver converts into DNP. As of 26 Oct 2026. 9

  1. Preclinical Standard tool of mitochondrial research
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 no registered trial
  5. Approval not yet
Not approved. Banned for human use in many countries since 1938. The precursor HU6 is in phase 2 trials but is not comparable with free DNP in a tablet.2

So far there is no registered trial in humans. 9

Side effects

DNP has the narrowest safety window in the entire range. The framing belongs ahead of any list: the central risk is not a side effect but death from hyperthermia. No antidote exists.

  • Fatal hyperthermia. The central danger mechanism. Body temperature rises faster than the body can shed it. The process reinforces itself. In the international poisons centre analysis just under 12 percent of cases with a known outcome were fatal. In the UK analysis it was 5 of 30.
  • Heart and circulation. Tachycardia is among the most common signs. Blood pressure falls as poisoning progresses.
  • Kidneys. Acute renal failure is described as part of the poisoning picture.
  • Common signs. Fever, heavy sweating, rapid breathing or breathlessness, nausea, abdominal pain, agitation and headache, plus yellow discolouration of the skin, the whites of the eyes and the urine. These signs are not the body getting used to it, they can be the start of poisoning.
  • From medical use in the 1930s. Rashes as the most common side effect, rapidly developing cataracts usually with permanent loss of vision, prolonged nerve inflammation in the hands and feet, a dangerous drop in white blood cells (agranulocytosis) and in some cases permanent deafness.
  • Amplifiers. Sauna, intense training, heat and too little fluid raise the danger markedly, because they impede heat loss. With repeated intake the compound can build up. In the UK case series repeated intake was more common than a single overdose.

As early as 1938 the US classified DNP as extremely dangerous and not fit for human consumption. The current toxicology literature reaches the same conclusion. For questions about metabolism, research offers approaches with a far better studied safety profile. This classification does not replace medical advice.

Emergency. Fever, a feeling of overheating, a racing heart or confusion after taking DNP are an emergency: call emergency services straight away (112 in the EU, the local emergency number elsewhere), cool the body until the ambulance arrives and tell the paramedics explicitly that DNP is involved.

Tolerability

Tolerability of the precursor HU6

There is no trial with free DNP, only poisoning cases. The only controlled frequencies come from the trial with the precursor HU6 over 61 days.

10 of 100 Placebo
32 of 100 Precursor HU6
Event PlaceboPrecursor HU6
Flushing6 10%32%
Diarrhoea6 0%25%
Palpitations6 5%12%

All HU6 levels combined. Three people on HU6 and two on placebo stopped because of side effects. No serious adverse events. These values apply to the controlled-release precursor, not to DNP tablets.6

Storage

Store dry, at room temperature, protected from light and away from heat sources, keep the tin closed and mind the expiry date. Do not keep it in the bathroom, the humidity there degrades tablets.

With this substance storage means more than usual: keep it strictly separate from everything else and unmistakably labelled, never decanted into an unlabelled container. Mix-ups cannot be corrected for a compound that has no antidote.

Keep out of reach of children and pets and do not put it in household waste. Leftovers belong at a hazardous waste collection point.

Three white tablet bottles and a folded light blue towel on a white shelf
Store separately, clearly labelled and out of reach of children. Symbolic image.

Related

Related compounds

Same targets or a different path: all in the TPD lexicon.

FAQ

Common questions about DNP (2,4-dinitrophenol)

Short answers, each backed by the sources below.

Why does this entry give no dose?

There are no modern controlled human trials with the free substance. Almost all data come from poisoning cases in emergency departments. Even in the medical use of the 1930s the desired and the toxic effect were close together. No reliable figure can be derived from that.21

How does DNP work?

DNP is a mitochondrial uncoupler. It carries protons back into the mitochondria past ATP synthase. Energy from fat and sugar is then not stored as ATP but released as heat, so the cell burns more for the same result. Exactly how this works at the molecular level is still not fully understood.5

How dangerous is DNP?

A 2011 review counted 62 deaths documented in the medical literature. Of 456 cases reported to poisons centres in 38 countries, 11.9 percent were fatal where the outcome was known. In the UK 5 of 30 reported people died, four of them after an acute overdose. In the UK analysis repeated use over days was more common than a single overdose.134

What are the warning signs?

In the UK cases fever, racing heart and heavy sweating were the most common, along with nausea, breathing difficulties, skin discolouration, abdominal pain, agitation and headache. The classic picture is overheating with a racing heart, sweating and rapid breathing. These signs are an emergency: call the emergency number straight away and say that DNP is involved.41

Is there an antidote?

No. There is no specific antidote for the poisoning, only the consequences such as overheating, circulation and kidneys are treated. Researchers see the reason in the fact that the exact molecular process of uncoupling is not yet understood.25

What is HU6?

HU6 is a precursor that the liver converts into DNP, meant to release it in a controlled way. In a phase 2a trial with 80 adults liver fat fell by 26.8 to 35.6 percent in 61 days, on placebo it rose by 5.4 percent. In heart failure with obesity participants lost 2.86 kg more than on placebo over 19 weeks, exercise capacity did not change. This is not comparable with DNP tablets.67

How does DNP differ from BAM15?

Both are uncouplers. BAM15 was described in 2014 as a new uncoupler that does not depolarise the outer cell membrane. So far it has only been studied in cells and animals. DNP has been known for almost a hundred years, the human data come from the time before the ban and from poisonings.81

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

Antidote
A compound that specifically cancels a poison. There is none for DNP.
ATP and ATP synthase
ATP is the energy currency of the cell. ATP synthase makes it using the proton gradient.
Cataract
Clouding of the lens of the eye that worsens vision.
Hyperthermia
Dangerous overheating of the body because more heat is produced than it can give off.
Mitochondria
Power plants of the cell. Inside them fat and sugar are turned into energy using oxygen.
Mitochondrial uncoupler
A substance that separates energy release in the mitochondria from ATP production. The energy is lost as heat.
Oxidative phosphorylation
Last step of cell respiration in which the mitochondria make most of the ATP.
Poisons centre
Advice service for poisonings. Its reports show how often and how severely poisonings occur.
Precursor (prodrug)
A substance that the body first converts into the actual compound. HU6 becomes DNP in the liver.
Protonophore
A molecule that carries protons across a membrane and so runs down the proton gradient of the mitochondria.
Racing heart (tachycardia)
A clearly too fast heartbeat at rest.

Tutkimusnäyttö

Lähteet

Show all 10 sourcesHide sources 8 Studies1 Trial registry1 Database checked 26 Oct 2026

Studies

  1. Review: acute toxicity and 62 documented deaths

    Grundlingh et al., Journal of Medical Toxicology, 2011

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. Overview of use, ban, poisoning and treatment

    Sousa et al., Archives of Toxicology, 2020

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. 456 cases at poisons centres in 38 countries

    Gziut und Thomas, Clinical Toxicology, 2021

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  4. 30 reported poisonings in the UK

    Kamour et al., Emergency Medicine Journal, 2014

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  5. Molecular mechanism of uncoupling by DNP

    Pohl und Jovanović, European Biophysics Journal, 2026

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  6. Precursor HU6 in fatty liver and overweight, phase 2a

    Noureddin et al., Lancet Gastroenterology and Hepatology, 2023

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed, ClinicalTrials.gov
  7. Precursor HU6 in heart failure with obesity, phase 2a

    Pandey et al., JAMA Cardiology, 2025

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed, ClinicalTrials.gov
  8. BAM15: an uncoupler that spares the plasma membrane

    Kenwood et al., Molecular Metabolism, 2014

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Search on ClinicalTrials.gov (no trial with DNP)

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. Structure of 2,4-dinitrophenol in PubChem

    PubChem, U.S. National Library of Medicine (CID 1493)

    Checked 26 Oct 2026 via PubChem

Kaupassa

DNP (2,4-dinitrophenol) in the catalog

Koot, hinnat ja toimitusajat löytyvät tuotesivulta.

Tuotteeseen